jacob lalezari
Interviews and expert commentary tagged “jacob lalezari” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Maraviroc for HIV: Responses at 48 Weeks
Jacob Lalezari REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JACOB LALEZARI, Quest Clinical Research, San Francisco Maraviroc could be a
20 September 2007
0:00